While the ketogenic diet has emerged as a promising nutritional intervention in cancer therapy, the core signaling pathway through which ketone body ...
Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable safety profile and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results